drugset / Trial / NCT01060579
Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
RandomizedParallel-groupDouble-blindTreatment
Summary
A 28 day study of the safety and efficacy of two concentrations of topical AR-12286 in treating ocular hypertension and open-angle glaucoma compared to latanoprost. Hypothesis: The ocular hypotensive efficacy of each dose of AR-12286 ophthalmic solution will not be different from that of an active control.
Timeline
- Start
- 2010-02
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latanoprost | Small molecule | 0.005 % | Topical |
| Subject | VEROSUDIL | Small molecule | 0.25 % | Topical |
| Subject | VEROSUDIL | Small molecule | 0.5 % | Topical |